Zodasiran Reduces Triglycerides, ANGPTL3 in Mixed Hyperlipidemia in ARCHES-2 Trial
A phase 2 trial suggests zodasiran significantly reduces triglycerides in patients with mixed hyperlipidemia, showing dose-dependent improvements in lipid profiles.
Stay updated with breaking news from Cura Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A phase 2 trial suggests zodasiran significantly reduces triglycerides in patients with mixed hyperlipidemia, showing dose-dependent improvements in lipid profiles.
Adults with higher triglyceride levels exhibit a higher prevalence of chronic conditions and multi-organ disease.
Dr. Max Gomez began his 40 year television career with CBS Philadelphia before heading to New York and joined Fox 5 New York. He moved to NBC 4 New York and then CBS New York in 1994.
Dr. Max Gomez began his 40 year television career with CBS Philadelphia before heading to New York and joined Fox 5 New York. He moved to NBC 4 New York and then CBS New York in 1994.
CHARITY ENTREPRENEUR, AUTHOR, GLOBAL SPEAKER TO DELIVER AVERETT UNIVERSITY’S SPRING COMMENCEMENT ADDRESS